Vertex forecasts upbeat 2025 revenue on cystic fibrosis treatments demand
Vertex Pharmaceuticals forecast annual revenue largely above Wall Street estimates on Monday, banking on robust sales of its ...
How the brain can miraculously switch off pain
In the second world war, the physician Henry Beecher observed that some of his soldier patients, despite being injured on the ...
The FDA just approved a new painkiller. Is it too good to be true?
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
Opinion: Maine’s seniors need better access to safe pain medication
Medicare needs to cover non-opioid treatments instead of riskier ones. A new legislative proposal can help cover the cost.
BioSpace3d
FDA Approval of Vertex’s Non-Opioid Journavx Signals New Era in Pain Treatment
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
News on 63d
New non-opioid drug offers hope for pain management
Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...
National Academies of Sciences%2c Engineering%2c and Medicine4d
New Report Finds Co-Prescribing Opioids and Benzodiazepines to Veterans at VHA from 2007 to 2019 Increased Their Risk of Death
A new congressionally mandated report examines how opioid and benzodiazepine prescribing between 2007 and 2019 impacted ...
CenExel Celebrates FDA Approval of JOURNAVX(TM), a Groundbreaking Non-Opioid Pain Treatment
CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...
Yale Daily News4d
First FDA-approved non-addictive painkiller has Yale roots
Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
dermatologyadvisor5d
FDA Approves First New Non-Opioid Pain Pill in Decades
The US FDA has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
Vistagen secures patent for non-opioid pain treatment
SOUTH SAN FRANCISCO, Calif. - Vistagen Therapeutics (VTGN), a clinical-stage biopharmaceutical company with a market ...
Sanjay Gupta: New non-opioid pain medication ‘a pretty big deal’
Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...